Literature DB >> 18228448

Flow cytometry of apoptosis.

Piotr Pozarowski1, Jerzy Grabarek, Zbigniew Darzynkiewicz.   

Abstract

Common methods applicable to flow cytometry make it possible to: (1) identify and quantify dead or dying cells, (2) reveal a mode of cell death (apoptosis or necrosis), and (3) study mechanisms involved in cell death. Gross changes in cell morphology and chromatin condensation, which occur during apoptosis, can be detected by analysis with laser light beam scattering. Early events of apoptosis, dissipation of the mitochondrial transmembrane potential and caspase activation, can be detected using either fluorochrome reporter groups or appropriate antibodies. Exposure of phosphatidylserine on the exterior surface of the plasma membrane can be detected by the binding of fluoresceinated annexin V. Another apoptotic event, DNA fragmentation based on DNA content of cells with fractional ("sub-G1") or DNA strand-break labeling, TUNEL; or In Situ End Labeling, ISEL;. Still another hallmark of apoptosis is the activation of tissue transglutaminase (TGase), the enzyme that crosslinks protein and thereby makes them less immunogenic. The major advantage of flow cytometry in these applications is that it provides the possibility of multiparametric measurements of cell attributes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 18228448     DOI: 10.1002/0471143030.cb1808s21

Source DB:  PubMed          Journal:  Curr Protoc Cell Biol        ISSN: 1934-2616


  8 in total

1.  A novel aminosteroid of the 5α-androstane-3α,17β-diol family induces cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.

Authors:  Hajer Jegham; Jenny Roy; René Maltais; Serge Desnoyers; Donald Poirier
Journal:  Invest New Drugs       Date:  2010-10-02       Impact factor: 3.850

2.  Vascular Endothelial Cell Growth Factor A Acts via Platelet-Derived Growth Factor Receptor α To Promote Viability of Cells Enduring Hypoxia.

Authors:  Steven Pennock; Leo A Kim; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

3.  Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade.

Authors:  Robert Godal; Veronika Bachanova; Michelle Gleason; Valarie McCullar; Gong H Yun; Sarah Cooley; Michael R Verneris; Philip B McGlave; Jeffrey S Miller
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-06       Impact factor: 5.742

4.  Flow cytometric analysis of BDE 47 mediated injury to rainbow trout gill epithelial cells.

Authors:  Jing Shao; Michael J Dabrowski; Collin C White; Terrance J Kavanagh; Evan P Gallagher
Journal:  Aquat Toxicol       Date:  2009-12-11       Impact factor: 4.964

5.  Characterization of adipose-derived stem cells of anatomical region from mice.

Authors:  Arthur C L Luna; Maria E P Madeira; Thais O Conceição; José A L C Moreira; Rosa A N Laiso; Durvanei A Maria
Journal:  BMC Res Notes       Date:  2014-08-20

6.  Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors.

Authors:  Chun-Nan Yeh; Chueh-Chuan Yen; Yen-Yang Chen; Chi-Tung Cheng; Shih-Chiang Huang; Ting-Wei Chang; Fang-Yi Yao; Yung-Chan Lin; Yao-Shan Wen; Kun-Chun Chiang; Jen-Shi Chen; Ta-Sen Yeh; Cheng-Hwai Tzeng; Ta-Chung Chao; Jonathan A Fletcher
Journal:  Oncotarget       Date:  2014-06-30

7.  Depletion of HDAC6 enhances cisplatin-induced DNA damage and apoptosis in non-small cell lung cancer cells.

Authors:  Lei Wang; Shengyan Xiang; Kendra A Williams; Huiqin Dong; Wenlong Bai; Santo V Nicosia; Saadi Khochbin; Gerold Bepler; Xiaohong Zhang
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

8.  Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth.

Authors:  Robbert G van der Most; Andrew J Currie; Amanda L Cleaver; Joanne Salmons; Anna K Nowak; Sathish Mahendran; Irma Larma; Amy Prosser; Bruce W S Robinson; Mark J Smyth; Anthony A Scalzo; Mariapia A Degli-Esposti; Richard A Lake
Journal:  PLoS One       Date:  2009-09-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.